L G Balakrishnan & Bros Share Price

India's economic growth to exceed 6.5% in FY26, says Moody's Ratings

Delhivery, Tata: Trading strategies in stocks that hit 52-week lows

Gensol Engineering shares plunge 50% in 12 days; rating downgrades weigh

Global funds' asset under custody see second-worst plunge amid market rout

Zydus Lifesciences to buy 86% stake in Amplitude Surgical for $280 million

In compliance with Regulation 39(3) of the SEBI LODR Regulations 2015 and based on the intimation received from the Companys Registrar and Share Transfer Agents M/s Cameo Corporate Services Limited we would like to inform you regarding the loss of the share certificate(s) and request for issue of duplicate shares certificate(s).The duplicate share certificate(s) will be issued after receipt of all necessary documents from the shareholder(s) and compliance of required formalities.

Pursuant to Section 124 of the Companies Act 2013 (the Act) Investor Education and Protection Fund Authority (Accounting Audit Transfer and Refund) Rules 2016 as amended (the Rules) and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the following documents: 1. Copies of the advertisement published giving Notice of Transfer of Equity Shares of the Company to Investor Education and Protection Fund Authority as follows: a) Financial Express (English - All India Edition) issue dated January 28 2023b) Maalai Malar (Tamil - Tamilnadu Edition) issue dated January 27 2023The above information is also available on the Companys website i.e. www.lgb.co.in.

Pursuant to Regulation 47(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please note that the Audited Financial Results of the Company for the Quarter ended December 31 2022 were published in Financial Express and Maalai Malar on January 29 2023. Copies of the same are enclosed for your information and records.

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are forwarding herewith the Standalone & Consolidated audited financial results for the quarter / nine months ended 31st December 2022 along with Auditors Report which were reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on today i.e. the 28th January 2023

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are forwarding herewith the Standalone & Consolidated audited financial results for the quarter / nine months ended 31st December 2022 along with Auditors Report which were reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on today i.e. the 28th January 2023.This is to inform that the Board meeting commenced at 3.15 P.M and concluded at 5.20 P.M.